Status:
COMPLETED
Virtual Exercise for Multiple Myeloma
Lead Sponsor:
University of Alberta
Conditions:
Multiple Myeloma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary objective of this pilot study is to determine the safety and feasibility a 12-week virtually supported home-based aerobic and resistance exercise program progressing cancer survivors with ...
Detailed Description
Multiple myeloma (MM), a cancer of the plasma cells in bone marrow, is associated with osteolytic bone destruction, leading to deformities, chronic pain, reduced mobility and functioning, fatigue, and...
Eligibility Criteria
Inclusion
- 18 years of age and older
- Diagnosis of multiple myeloma
- In one of the following three treatment categories:
- Transplant ineligible patients, currently in first line treatment
- Transplant eligible patients, sufficiently recovered from transplantation (\>3 months following transplantation)
- Patients with relapsed/recurrent myeloma with either 1-3 prior lines of treatment or 4+ prior lines
- Able to provide informed written consent in English
- Approved for physical activity participation by their oncologist and cleared for physical activity by the Certified Exercise Physiologist on the PAR-Q+
Exclusion
- Unstable cardiac/metabolic condition that would be deemed unsafe to exercise
- Severe anemia
- Spinal instability requiring surgical intervention
- AL amyloidosis, solitary plasmacytoma, or Waldenstrom macroglobulinemia
- Too frail to participate in home exercise, as determine by baseline physical assessment (i.e., unable to complete a single sit-to-stand or balance on one foot for ≥ 3 seconds).
- Inability to provide consent
- Inability to commit to, and/or comply with the intervention due to personal reasons (e.g. vacation planned during the intervention period)
Key Trial Info
Start Date :
September 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2021
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT04484714
Start Date
September 15 2020
End Date
August 31 2021
Last Update
September 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alberta/ Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 2G4